Definition for covered insulin provided for the insulin safety net program and manufacturer registration fee.

HF 3756 defines "covered insulin" for Minnesota's insulin safety net program, clarifying that it includes any insulin drug prescribed for diabetes treatment (excluding intravenous-only products). This definition directly affects manufacturers, pharmacies, and patients seeking urgent insulin access under the program. Key provisions require manufacturers to provide covered insulin to eligible individuals in urgent need, while pharmacies must verify eligibility through MNsure's application process. The bill also exempts manufacturers with under $2 million in annual Minnesota insulin sales and sets a $8 per milliliter cost threshold for automatic exemption from certain requirements. These changes standardize eligibility and program operations for insulin access.